Market Cap 37.12M
Revenue (ttm) 0.00
Net Income (ttm) -41.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,435,400
Avg Vol 2,867,934
Day's Range N/A - N/A
Shares Out 53.35M
Stochastic %K 93%
Beta 1.38
Analysts Strong Sell
Price Target $6.00

Latest News on MIST

FDA Issues Complete Response Letter for Etripamil for PSVT

Mar 28, 2025, 7:00 AM EDT - 4 weeks ago

FDA Issues Complete Response Letter for Etripamil for PSVT


Milestone Pharmaceuticals: Worthy Of A Dart Throw

May 22, 2023, 2:37 PM EDT - 2 years ago

Milestone Pharmaceuticals: Worthy Of A Dart Throw